ChineseInvestors.com announced that it has established and registered XiBiDi Biotechnology Co. Ltd. in the Pudong Free-Trade Area in Shanghai, with registered capital requirements of USD 1.45 million over the next 10 ears. XiBiDi Biotechnology will focus on the online and offline sales of health products including hemp-derived CBD (cannabidiol) oil, as well as hemp-based food and beverages. The establishment of XiBiDi Biotechnology supplements these ventures as well as the Company’s broader mission to develop its presence in the hemp industry. In addition to retail and direct sales, the Company will focus on the legal import of hemp-based (but not CBD oil products) health products in China – a population increasingly interested in the health benefits of hemp and CBD oil - and the export of hemp food and beverages to the United States, Canada and Europe.